The Effectiveness of the Android Application as a Pharmaceutical Education Tool in Hypertensive Patients

Hypertension Clinical Trial

Official title:

The Influence of Android Application as a Pharmaceutical Education Tool on Knowledge, Adherence, Clinical Outcome and Quality of Life of Hypertension Prolanis Patients: A Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05728723
• Other study ID #: Pharm-202301.01
• Status: Completed
• Phase: N/A
• Start date: March 16, 2023
• Est. completion date: June 16, 2023

Study information

• Verified date: July 2023
• Source: Universitas Padjadjaran
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Hypertension is a worldwide public health challenge due to its high prevalence and along with increased risk of complications of other diseases that are more dangerous if not managed properly. An estimated 1.4 billion people worldwide have high blood pressure, but only 14% can control it. Knowledge of hypertension in patients with hypertension can prevent complications through hypertension treatment. Increasing knowledge can be done by providing education in the form of counseling by pharmacists to hypertensive patients. Counseling activities carried out by pharmacists can be supported by a technological approach. One of the uses in smartphone technology is by creating an android-based mobile application that can be developed to support pharmaceutical care. Education conducted by pharmacists can increase knowledge that will affect hypertension treatment adherence, and this education can also improve blood pressure control so that it can improve the quality of life. The purpose of this study is to analyze the influence of the android application as a standard pharmacist education tool on knowledge as well as adherence and therapeutic outcomes of hypertensive patients, and quality of life related to the health of hypertensive patients compared to just providing standard education by pharmacists to hypertensive patients at the Primary Health Care. The method used in this study is a Quasi-Experimental with Pretest - Posttest Control Group Design. Samples were obtained by purposive sampling method at the selected Primary Health Care as the intervention group and the selected Primary Health Care as the control group. Pharmacist provides education to intervention groups with android applications as counseling aids and in control groups only standard counseling is provided. Pre-test data collection was done by taking primary and secondary data of patients at the first meeting and post-test data collection was taken prospectively through face-to-face interviews and questionnaires on hypertensive patients participants for three months by observing the influence of android applications as counseling aids on knowledge of hypertensive diseases, adherence to antihypertensive treatment, outcome therapy and quality of life.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: June 16, 2023
• Est. primary completion date: June 16, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients aged = 18 years, male and female who are willing to be respondents.

• Patients diagnosed with hypertension or currently taking = 1 antihypertensive drug.

• Hypertension patients who carry out routine control and receive anti-hypertensive drugs for at least 3 months at the Health Center.

• Not illiterate and owns a smartphone.

• Patients who are willing to participate in the study by signing an informed consent.

Exclusion Criteria:

• Physical and mental disabilities such as deaf, blind, and psychiatric disorders.

• The patient is pregnant

• Currently taking hormonal drugs and other routine drugs such as TB, HIV and AIDS drugs.

Related Conditions & MeSH terms

• Hypertension

Intervention

Device:
• Android Application
Android Application for 3 months

Behavioral:
• Pharmacy education
Pharmacy education in hypertensive patients

Locations

Country	Name	City	State
Indonesia	Health Centers	Bandar Lampung	Lampung

Sponsors (1)

Lead Sponsor	Collaborator
Universitas Padjadjaran

Country where clinical trial is conducted

Indonesia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Knowledge about hypertension	Measured by Hypertension Knowledge-Level Scale (HK-LS) questionnaires	At day 90 after treatment
Primary	Adherence to antihypertensive treatment	Measurement by Medication Adherence Report Scale (MARS) questionnaires	At day 90 after treatment
Secondary	Blood pressure	Measurement by blood pressure measuring device.	90 days
Secondary	Quality of life related to the health	Measurement by Short Form-36 (SF-36) questionnaires	90 days